• sales@syndicatedanalytics.com
  • +1-213-316-7435

Hypertension Drugs Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2022-2027



Global Hypertension Drugs Market: Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2022-2027” provides a deep and thorough evaluation of the global hypertension drugs market. Hypertension drugs are used to treat individuals suffering from high blood pressure, also called as hypertension. Hypertension is a major disorder with serious complications, such as heart failure, heart attack, and dementia, and thus requires immediate diagnosis and treatment. The major known causes of hypertension include diabetes, kidney diseases, cardiovascular diseases, and obstructive sleep. Some commonly used hypertension drugs include ACE inhibitors, diuretics, and vasodilators. In recent years, hypertension drugs have gained traction due to increasing expenditure on health issues.

One of the primary factors driving the market is the rising prevalence of hypertension Other than this,is propelling the market growth. across the globe. Additionally, the rising consciousness about the complications linked with hypertension is creating a positive market outlook. Other than this, the increasing geriatric population and sedentary lifestyle is propelling the market growth. Besides this, a surge in the incidence of cardiovascular diseases due to the changing demographics and increasing number of individuals diagnosed with stroke and diabetes are propelling the market growth. In line with this, the declining fertility rate and improved longevity are vital factors that are positively influencing the market. Furthermore, the increasing aging population globally is strengthening the market growth. Apart from this, there is a rise in the number of baby boomers (members of the demographically large generation born between the end of WWII and the mid-1960s) who are vulnerable to a wide range of age-related diseases, consequently catalyzing the market growth. Other than these factors, the extensive growth in telemedicine and e-health apps is also driving the hypertension drugs market. Moreover, the extensive research and development (R&D) activities performed by ley players to develop novel therapies and drugs for hypertension, including angiotensin II receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors, and calcium channel blockers (ARBs). Other growth-inducing factors include initiatives by private and government initiatives, key industry developments such as collaborations and establishment of new R&D centers, and the rising awareness about hypertension worldwide.

Beginning with a global overview, the report explores the dynamics that have a strong influence on the hypertension drugs market and can also impact its future growth. Taking 2021 as the base year, the report covers the historical market scenarios from 2016-2021 and provides forecasts till 2027. This includes the study of value and volume trends and pricing history. Growth-inducing factors, market restraints, and recent developments have also been analyzed in the report in order to provide deeper knowledge about the industry. On a regional basis, the report examines the hypertension drugs market in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each of these regions, the report studies the hypertension drugs market in detail for the latest trends, outlook, and opportunities.

The report analyses the competitive structure of the hypertension drugs industry and provides the profiles of major players operating in the market. The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the hypertension drugs industry along with the parameters of Porter’s Five Forces model. This model examines the degree of competition in the hypertension drugs industry by analyzing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities, and threats pertaining to the hypertension drugs industry. Furthermore, the value chain analysis of the hypertension drugs industry has also been covered in the report. This comprises all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales, and distribution. 

Segmentation by Type:                                           

  • Pulmonary Hypertension Drugs
  • Systemic Hypertension Drugs

Segmentation by Region:

  • North America
  • Europe
  • Asia-pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape:

  • Novartis
  • Actelion Pharmaceuticals
  • Sanofi
  • Daiichi Sankyo
  • Actelion Pharmaceuticals
  • Boehringer Ingelheim
  • Others

The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the hypertension drugs industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the hypertension drugs industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the hypertension drugs industry. Furthermore, the value chain analysis of the hypertension drugs industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.

Highlights of the Global Hypertension Drugs Market

  • Historical and current scenario
  • Trends and developments
  • Market forecast
  • Price analysis and forecast
  • Porter’s five forces analysis
  • SWOT analysis
  • Value chain analysis

The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the hypertension drugs industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.

1 Introduction 
    1.1 Research Objectives 
    1.2 Stakeholders
    1.3 Scope of the Report
    1.4 Assumptions and Limitations
2. Research Methodology 
    2.1. Data Collection
       2.1.1 Primary Sources
       2.1.2 Secondary Sources
    2.2 Market Size Estimation
        2.2.1 Bottom-Up Approach
        2.2.2 Top-Down Approach
    2.3 Data Validation
3. Executive Summary
4. Global Hypertension Drugs Market

     4.1 Industry Overview
     4.2 Key Industry Developments
     4.3 Market Trends
        4.3.1 Key Market Indicators
        4.3.2 Historical Market Trends
        4.3.3 Market Forecast
     4.4 Price Analysis
        4.4.1 Key Price Indicators
        4.4.2 Pricing Structure
        4.4.3 Historical Price Trends
        4.4.4 Price Forecast
     4.5 Market Breakup by Region
     4.6 Market Breakup by Type
5. Global Hypertension Drugs Market: Value Chain Analysis
     5.1 Overview
     5.2 Research and Development
     5.3 Raw Material Suppliers
     5.4 Inbound Logistics
     5.5 Production
     5.6 Marketing 
     5.7 Outbound Logistics
     5.8 Consumers
6. Global Hypertension Drugs Market: SWOT Analysis
     6.1 Overview
     6.2 Strengths
     6.3 Weaknesses
     6.4 Opportunities
     6.5 Threats
7. Global Hypertension Drugs Market: Porter’s Five Forces Analysis
     7.1 Overview
     7.2 Threat of New Entrants
     7.3 Threat of Substitutes
     7.4 Bargaining Power of Buyers
     7.5 Bargaining Power of Suppliers
     7.6 Intensity of Rivalry
8.  Competitive Landscape
     8.1 Market Structure
     8.2 Key Players 
     8.3 Key Success Factors 
9. Performance by Region
     9.1 North America
         9.1.1 Overview
         9.1.2 Market Trends
         9.1.3 Market Segmentation
         9.1.4 Market Forecast
     9.2 Europe
         9.2.1 Overview
         9.2.2 Market Trends
         9.2.3 Market Segmentation
         9.2.4 Market Forecast
     9.3 Asia Pacific 
        9.3.1 Overview
        9.3.2 Market Trends
        9.3.3 Market Segmentation
        9.3.4 Market Forecast
     9.4 Latin America
        9.4.1 Overview
        9.4.2 Market Trends
        9.4.3 Market Segmentation
        9.4.4 Market Forecast
     9.5 Middle East and Africa
        9.5.1 Overview
       9.5.2 Market Trends
       9.5.3 Market Segmentation
       9.5.4 Market Forecast
10 Key Player Profiles

List of Figures

    

Figure 1: Global: Hypertension Drugs Market, 2016-2021
Figure 2: Global: Hypertension Drugs Market Forecast, 2022-2027
Figure 3: Global: Hypertension Drugs Market: Price Trends, 2016-2021
Figure 4: Global: Hypertension Drugs Market Forecast: Price Trends, 2022-2027
Figure 5: Global: Hypertension Drugs Market: Breakup by Region, 2021
Figure 6: Global: Hypertension Drugs Market: Breakup by Type, 2021
Figure 7: Global: Hypertension Drugs Market: Breakup by End Use, 2021
Figure 8: Global: Hypertension Drugs Industry: Value Chain Analysis
Figure 9: Global: Hypertension Drugs Industry: SWOT Analysis
Figure 10: Global: Hypertension Drugs Industry: Porter’s Five Forces Analysis
Figure 11: Global: Hypertension Drugs Market: Key Players
Figure 12: North America: Hypertension Drugs Market, 2016-2021
Figure 13: North America: Hypertension Drugs Market: Breakup by Segment, 2021
Figure 14: North America: Hypertension Drugs Market Forecast, 2022-2027
Figure 15: Europe: Hypertension Drugs Market, 2016-2021
Figure 16: Europe: Hypertension Drugs Market: Breakup by Segment, 2021
Figure 17: Europe: Hypertension Drugs Market Forecast, 2022-2027
Figure 18: Asia Pacific: Hypertension Drugs Market, 2016-2021
Figure 19: Asia Pacific: Hypertension Drugs Market: Breakup by Segment, 2021
Figure 20: Asia Pacific: Hypertension Drugs Market Forecast, 2022-2027
Figure 21: Latin America: Hypertension Drugs Market, 2016-2021
Figure 22: Latin America: Hypertension Drugs Market: Breakup by Segment, 2021
Figure 23: Latin America: Hypertension Drugs Market Forecast, 2022-2027
Figure 24: Middle East and Africa: Hypertension Drugs Market, 2016-2021
Figure 25: Middle East and Africa: Hypertension Drugs Market: Breakup by Segment, 2021
Figure 26: Middle East and Africa: Hypertension Drugs Market Forecast, 2022-2027


List of Tables

Table 1: Global: Hypertension Drugs Industry: Market Summary    
Table 2: Global: Hypertension Drugs Industry: Market Overview, 2021 and 2027
Table 3: Global: Hypertension Drugs Industry: Market Structure    
Table 4: Global: Hypertension Drugs Market: Market by Region, 2022-2027    

Special Prices


    Syndicated Analytics provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations

  • For more information, feel free to contact us.





Related Reports

Saudi Arabia Health Insurance Market by Type (Individual and Group) by Service Provider (Public and Private): Industry Analysis, Trends, Growth and Forecast 2022-2027

The Saudi Arabia health insurance market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027.

Saudi Arabia In-Vitro Diagnostics (IVD) Market by Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases and Others) End-User (Hospital-Based Centres, Diagnostics Chains, Standalone Centres and Others): Industry Analysis, Trends, Growth and Forecast 2022-2027

The Saudi Arabia in-vitro diagnostics (ivd) market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027. 

GCC Intravenous Solutions Market by Type (Partial Parenteral Nutrition and Total Parenteral Nutrition) by Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins and Amino Acids): Industry Analysis, Trends, Growth and Forecast 2022-2027

The GCC intravenous solutions market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027.

UAE mHealth Market by Components, by Service Type, by Stakeholders and by Application: Industry Analysis, Trends, Growth and Forecast 2022-2027

The UAE mhealth market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027.

UAE In-Vitro Diagnostics Devices Market by Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases and Others) by End-User (Hospital-Based Centres, Diagnostics Chains, Standalone Centres and Others): Industry Analysis, Trends, Growth and Forecast 2022-2027

The UAE in vitro diagnostics devices market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027.